|
|
||||||||
From the Department of Neurology, Mayo Clinic, Rochester, MN.
Address correspondence and reprint requests to Dr. Phillip A. Low, Mayo Clinic, Department of Neurology, Guggenheim 811, 200 First Street SW, Rochester, MN 55905; e-mail: low{at}mayo.edu
Background: Blood pressure (BP) changes in response to the Valsalva maneuver (VM) reflect the integrity of the baroreflex that regulates BP, and the phases of VM are widely used indices of adrenergic evaluation.
Objective: To study the BP recovery time (PRT) following termination of VM back to baseline to determine if it could be an additional and better indicator of adrenergic function.
Methods: The authors evaluated three groups of patients with increasing degrees of adrenergic failure and an age-matched control group. Adrenergic failure was graded on the basis of systolic blood pressure (SBP) reduction to tilt: Group 1, orthostatic hypotension (OH; SBP
30 mm Hg); Group 2, borderline OH (BOH; 30 > SBP > 10 mm Hg); and Group 3, sympathetic sudomotor failure.
Results: PRT was found to vary directly with severity of adrenergic impairment. PRT significantly correlated with previously utilized phases of the VM and baroreflex gain, with highest correlations with phases II_L (reflex vasoconstriction following initial fall in BP) and IV (BP overshoot following the VM). PRT extends the indices for the quantitation of adrenergic failure, since it will continue to parallel increasing adrenergic failure after phase II_L is lost and is a reliable index when II_L cannot be recorded.
Conclusions: Pressure recovery time is a valuable index of adrenergic failure. It extends the value of the Valsalva maneuver by providing a quantitative index that is measurable in patients with severe adrenergic failure.
Commentary, see page 1517
Supported in part by grants from the National Institutes of Health (NS 32352, NS 44233, HD07447, NS 22352, NS 43364, RR15537), Mayo GCRC (MO1 RR00585), and Mayo Funds.
Disclosure: The authors report no conflicts of interest.
Received January 14, 2005. Accepted in final form August 10, 2005.
Related Article
Neurology 2005 65: 1517.
This article has been cited by other articles:
![]() |
D. S. Goldstein and Y. Sharabi Neurogenic Orthostatic Hypotension: A Pathophysiological Approach Circulation, January 6, 2009; 119(1): 139 - 146. [Full Text] [PDF] |
||||
![]() |
H. Oka, M. Yoshioka, M. Morita, K. Onouchi, M. Suzuki, Y. Ito, T. Hirai, S. Mochio, and K. Inoue Reduced cardiac 123I-MIBG uptake reflects cardiac sympathetic dysfunction in Lewy body disease Neurology, October 2, 2007; 69(14): 1460 - 1465. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Oka, M. Yoshioka, K. Onouchi, M. Morita, S. Mochio, M. Suzuki, T. Hirai, Y. Ito, and K. Inoue Characteristics of orthostatic hypotension in Parkinson's disease Brain, August 2, 2007; (2007) awm174v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Minguez-Castellanos, C. E. Chamorro, F. Escamilla-Sevilla, A. Ortega-Moreno, A. C. Rebollo, M. Gomez-Rio, A. Concha, and D. G. Munoz Do {alpha}-synuclein aggregates in autonomic plexuses predate Lewy body disorders?: A cohort study Neurology, June 5, 2007; 68(23): 2012 - 2018. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Schrezenmaier, W. Singer, N. M. Swift, D. Sletten, J. Tanabe, and P. A. Low Adrenergic and Vagal Baroreflex Sensitivity in Autonomic Failure Arch Neurol, March 1, 2007; 64(3): 381 - 386. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |